(READ) Pfizer recalls blood pressure drug Accupril after detecting high levels of a human carcinogen
Pfizer announced a nationwide recall of five lots of its blood pressure drug quinapril HCL (Accupril) after detecting unacceptable levels of nitrosamine, a human carcinogen. Read Pfizer’s official recall notification below: FOR IMMEDIATE RELEASE - NEW YORK, NY., April 22,2022 Pfizer is voluntarily recalling five (5) lots of Accupril (Quinapril HCl) tablets distributed by Pfizer to the patient […]
Continue reading (READ) Pfizer recalls blood pressure drug Accupril after detecting high levels of a human carcinogen on sharylattkisson.com.
